Using nutraceuticals in the management of major depressive disorder (MDD): Approach to be considered for sustainable healthcare systems
World Journal of Science, Technology and Sustainable Development
ISSN: 2042-5945
Article publication date: 3 January 2017
Abstract
Purpose
The purpose of this paper is to study evidence-based records on the impact of some effective nutraceuticals on major depression disorder management; and describe the antidepressant properties of nutraceuticals to achieve health policy targets and maintain a sustainable healthcare system.
Design/methodology/approach
The literature was searched using MEDLINE (PubMed), Google Scholar, PsycINFO and Quertile databases and retrieving relevant published articles in peer-reviewed journals.
Findings
The results provided evidence of a range of nutraceuticals with potential benefits in the management of depression. Studies support the anti-depressant properties of S-adenosyl methionine, folnic acid, 5-hydroxytryptophan and omega-3 fatty acids. The results might represent evidence for an innovative adjunctive neurobiological line for the management and treatment of depression.
Practical implications
Randomized-controlled trials and evaluations continue to provide evidence for the use of nutraceuticals in the treatment of depression.
Social implications
Nutraceuticals emphasize the personalized medicine, which offers a psychophysical balance to the individual.
Originality/value
Nutraceuticals have specific antidepressant properties that may be beneficial in psychiatric populations and reduce pharmacotherapeutic side effects.
Keywords
Citation
Khalifa, N. and Aljaaly, E.A. (2017), "Using nutraceuticals in the management of major depressive disorder (MDD): Approach to be considered for sustainable healthcare systems", World Journal of Science, Technology and Sustainable Development, Vol. 14 No. 1, pp. 50-59. https://doi.org/10.1108/WJSTSD-01-2016-0007
Publisher
:Emerald Publishing Limited
Copyright © 2017, Emerald Publishing Limited